AF
PPH icon

Alerus Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Alerus Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-84,214
Closed -$6.73M – 162
2023
Q3 		$6.73M Buy
84,214
+16,530
+24% +$1.33M 0.6% 47
2023
Q2 		$5.33M Buy
67,684
+5,921
+10% +$463K 0.45% 66
2023
Q1 		$4.79M Buy
61,763
+14,343
+30% +$1.11M 0.43% 68
2022
Q4 		$3.69M Buy
+47,420
New +$3.5M 0.34% 84

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Alerus Financial's PPH Position: Q4 2023 in Review

Alerus Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 84,214 shares — an estimated $6.73M sold.

Alerus Financial first reported a position in PPH in Q4 2022 and held it in 4 quarters. The position peaked at $6.73M in Q3 2023. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

  • Alerus Financial reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
  • Alerus Financial sold 84,214 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $6.73M.
  • Alerus Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and held it in 4 quarters.
  • Alerus Financial's VanEck Pharmaceutical ETF position peaked at $6.73M in Q3 2023.
  • 110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Alerus Financial's 13F filing for Q4 2023, filed 12 Feb 2024.